{"id":144873,"date":"2025-03-10T12:15:38","date_gmt":"2025-03-10T11:15:38","guid":{"rendered":"https:\/\/www.startupbusiness.it\/indaco-cdp-vc-and-fondazione-enea-invest-in-valo-therapeutics\/144873\/"},"modified":"2025-03-10T13:47:05","modified_gmt":"2025-03-10T12:47:05","slug":"indaco-cdp-vc-and-fondazione-enea-invest-in-valo-therapeutics","status":"publish","type":"post","link":"https:\/\/www.startupbusiness.it\/en\/indaco-cdp-vc-and-fondazione-enea-invest-in-valo-therapeutics\/144873\/","title":{"rendered":"Indaco, CDP VC and Fondazione ENEA invest in Valo Therapeutics"},"content":{"rendered":"\n

Valo Therapeutics reports that it has closed a total capital increase of EUR 19 million, part of which was raised in Europe and part in Australia, <\/strong>for the clinical development of its innovative immunological therapy for cancer treatments.<\/p>\n\n

The EUR 13 million European investment round was co-led by Indaco Venture Partners and CDP Venture Capital, with the support of the ENEA Tech and Biomedical Foundation, while a further EUR 6 million was raised by Australian investors, supported by lead investor Freeman Road (Family Office headed by Paul Porter), bringing the total capital to EUR 19 million.<\/strong><\/p>\n\n

Valo Therapeutics is a Finnish company, also founded by Vincenzo Cerullo,<\/strong> that is developing a new cancer immunotherapy. The new resources will allow Valo to expand and complete the Phase 1B clinical trial of its lead therapeutic candidate, PeptiCRAd, an innovative platform based on oncolytic viruses coated with tumour antigens<\/strong>, designed to enhance the immune response in patients with solid tumours. Clinical trials will be conducted in three countries: Italy, Australia and Germany. <\/p>\n\n

Part of the investment round will be invested in Italy and earmarked for the activities of the new Italian operating company, Valo Therapeutics Italy based in Naples, with the objective of developing strategic initiatives in southern Italy,<\/strong> including: the recruitment and treatment of patients in southern Italy, the start-up of large-scale production of oncolytic viruses, supporting product development up to the commercial phase, and the support of research activities in collaboration with academic and scientific institutions based in Naples and southern Italy.<\/p>\n\n

David Hinton, chairman of Valo, comments in a note: ‘We are thrilled to have secured this funding and to be supported by Indaco Venture Partners, through its specialised biotechnology fund, and by leading investors such as CDP Venture Capital and ENEA Biotech.<\/strong> This investment will enable Valo to start clinical trials in southern Italy and Australia. Looking to the long term, it will also allow us to scale up development, a crucial step for future Phase 2 clinical trials’. <\/p>\n\n

Giovanni Rizzo, partner in the Indaco BIO Biotech Fund at Indaco Venture Partners and member of Valo’s Board of Directors, adds: “Valo Therapeutics represents a unique opportunity thanks to two key elements: an innovative technological platform in the field of immunotherapy, applicable both to cancer and to other clinical indications, and an international team of excellence with investors ranging from Italy to Finland, from Australia to Germany. <\/strong>This investment will allow Valo to advance in the clinical development of PeptiCRAd, a new immunotherapy that, if successful, could revolutionise the treatment of solid tumours considered so far intractable’. <\/p>\n\n

Francesca Ottier, senior partner and head of CDP Venture Capital’s Fondo Italia Venture II says: ‘We are excited to support Valo Therapeutics in this important step of its growth path, marked by the opening of a new research and development centre in Naples.<\/strong> This investment represents an extraordinary opportunity to strengthen the biotech innovation ecosystem in Italy, enhance local talent and contribute to the development of cutting-edge solutions in cancer immunotherapy. We firmly believe in Valo Therapeutics’ vision and in the potential of the PeptiCRAd platform to revolutionise cancer treatment’. <\/p>\n\n

For CDP Venture Capital, the transaction was overseen by Ersilia Rendola<\/strong> and Paola Deidda,<\/strong> respectively partner and associate of CDP Venture Capital’s Fondo Italia Venture II – Fondo Imprese Sud.<\/strong><\/p>\n\n

Maria Cristina Porta, general manager of ENEA Tech and Biomedical, says: ‘We chose to invest in Valo Therapeutics in recognition of the project’s high scientific value in the field of immuno-oncology, one of the most innovative frontiers in the fight against cancer.<\/strong> This initiative is not only an opportunity to support international excellence, but also represents a strategic step to bring high-level skills and technologies back to Italy. Through this investment, we strengthen the value chain of the Italian biomedical sector, creating a significant impact on the national system, supporting research, attracting foreign investment and promoting opportunities in southern Italy, as well as offering innovative therapeutic solutions to Italian patients. All these objectives are perfectly in line with the Foundation’s mission’. (image taken from the Valo Therapeutics website)<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"

Finnish start-up with offices also in Italy and Australia closes a EUR 19 million round to develop cancer treatments<\/p>\n","protected":false},"author":125,"featured_media":144871,"comment_status":"open","ping_status":"open","sticky":true,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1317],"tags":[1791,2236,1143,1137,1321,1136],"companies":[2527],"journalist":[1518],"class_list":["post-144873","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-funding-news","tag-australia-en","tag-europa-en","tag-investments","tag-italy-en","tag-lifescience-en","tag-startup-en-2","companies-valo-therapeutics-en","journalist-editorial-staff-en"],"featured_sizes_urls":{"thumbnail":{"src":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2025\/03\/AdobeStock_606895568-for-sarcoma.webp","width":150,"height":100,"crop":false,"srcset":false,"alt":"trattamenti oncologici"},"large":{"src":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2025\/03\/AdobeStock_606895568-for-sarcoma.webp","width":480,"height":320,"crop":false,"srcset":false,"alt":"trattamenti oncologici"},"2048x2048":{"src":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2025\/03\/AdobeStock_606895568-for-sarcoma.webp","width":480,"height":320,"crop":false,"srcset":false,"alt":"trattamenti oncologici"}},"acf":[],"yoast_head":"\nIndaco, CDP VC and Fondazione ENEA invest in Valo Therapeutics<\/title>\n<meta name=\"description\" content=\"Finnish start-up with offices also in Italy and Australia closes a EUR 19 million round to develop cancer treatments\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.startupbusiness.it\/en\/indaco-cdp-vc-and-fondazione-enea-invest-in-valo-therapeutics\/144873\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Indaco, CDP VC and Fondazione ENEA invest in Valo Therapeutics\" \/>\n<meta property=\"og:description\" content=\"Finnish start-up with offices also in Italy and Australia closes a EUR 19 million round to develop cancer treatments\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.startupbusiness.it\/en\/indaco-cdp-vc-and-fondazione-enea-invest-in-valo-therapeutics\/144873\/\" \/>\n<meta property=\"og:site_name\" content=\"Startupbusiness.it\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-10T11:15:38+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-03-10T12:47:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2025\/03\/AdobeStock_606895568-for-sarcoma.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"480\" \/>\n\t<meta property=\"og:image:height\" content=\"320\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Emil Abirascid\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@emilabirascid\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Emil Abirascid\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/indaco-cdp-vc-and-fondazione-enea-invest-in-valo-therapeutics\\\/144873\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/indaco-cdp-vc-and-fondazione-enea-invest-in-valo-therapeutics\\\/144873\\\/\"},\"author\":{\"name\":\"Emil Abirascid\",\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/#\\\/schema\\\/person\\\/4e2760db2cb7ca47d635ea3d8d8486dd\"},\"headline\":\"Indaco, CDP VC and Fondazione ENEA invest in Valo Therapeutics\",\"datePublished\":\"2025-03-10T11:15:38+00:00\",\"dateModified\":\"2025-03-10T12:47:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/indaco-cdp-vc-and-fondazione-enea-invest-in-valo-therapeutics\\\/144873\\\/\"},\"wordCount\":685,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/indaco-cdp-vc-and-fondazione-enea-invest-in-valo-therapeutics\\\/144873\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.startupbusiness.it\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/AdobeStock_606895568-for-sarcoma.webp\",\"keywords\":[\"australia\",\"Europa\",\"investments\",\"italy\",\"lifescience\",\"startup\"],\"articleSection\":[\"Funding News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/indaco-cdp-vc-and-fondazione-enea-invest-in-valo-therapeutics\\\/144873\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/indaco-cdp-vc-and-fondazione-enea-invest-in-valo-therapeutics\\\/144873\\\/\",\"url\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/indaco-cdp-vc-and-fondazione-enea-invest-in-valo-therapeutics\\\/144873\\\/\",\"name\":\"Indaco, CDP VC and Fondazione ENEA invest in Valo Therapeutics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/indaco-cdp-vc-and-fondazione-enea-invest-in-valo-therapeutics\\\/144873\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/indaco-cdp-vc-and-fondazione-enea-invest-in-valo-therapeutics\\\/144873\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.startupbusiness.it\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/AdobeStock_606895568-for-sarcoma.webp\",\"datePublished\":\"2025-03-10T11:15:38+00:00\",\"dateModified\":\"2025-03-10T12:47:05+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/#\\\/schema\\\/person\\\/4e2760db2cb7ca47d635ea3d8d8486dd\"},\"description\":\"Finnish start-up with offices also in Italy and Australia closes a EUR 19 million round to develop cancer treatments\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/indaco-cdp-vc-and-fondazione-enea-invest-in-valo-therapeutics\\\/144873\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/indaco-cdp-vc-and-fondazione-enea-invest-in-valo-therapeutics\\\/144873\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.startupbusiness.it\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/AdobeStock_606895568-for-sarcoma.webp\",\"contentUrl\":\"https:\\\/\\\/www.startupbusiness.it\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/AdobeStock_606895568-for-sarcoma.webp\",\"width\":480,\"height\":320,\"caption\":\"trattamenti oncologici\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/\",\"name\":\"Startupbusiness.it\",\"description\":\"May the Force be with you!\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/#\\\/schema\\\/person\\\/4e2760db2cb7ca47d635ea3d8d8486dd\",\"name\":\"Emil Abirascid\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/84e46190ac811c9c62650621ceca8f65c1e967d6b06e6352fe183145dba0d7e9?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/84e46190ac811c9c62650621ceca8f65c1e967d6b06e6352fe183145dba0d7e9?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/84e46190ac811c9c62650621ceca8f65c1e967d6b06e6352fe183145dba0d7e9?s=96&d=mm&r=g\",\"caption\":\"Emil Abirascid\"},\"description\":\"Emil Abirascid (\u30a8\u30df\u30fc\u30eb\u30fb\u30a2\u30d3\u30e9\u30b7\u30c3\u30c9), giornalista, fondatore e direttore di Startupbusiness, il primo magazine sull\u2019ecosistema startup e innovazione italiano. Co-fondatore di Designtech, l\u2019hub di innovazione che avvicina il mondo del design con quello della tecnologia. Advisor di Austrian Business Agency, Emil Banca, Fondazione Symbola, Fondazione Quadrans. Partecipa regolarmente a incontri, convegni, conferenze dedicate all\u2019ecosistema dell\u2019innovazione. E\u2019 stato co-organizzatore degli Italian Innovation Day and Series che si sono svolti dal dal 2016 al 2020 nelle citt\u00e0 di Tokyo in Giappone, Melbourne, Adelaide, Perth, Canberra in Australia e Singapore e co-organizzatore dell\u2019Italy India Innovation Day di AIICP 2021 e 2022. Ha curato il volume \u2018L\u2019innovazione che non ti aspetti. Contesti e visioni per l\u2019impresa\u2019 , l\u2019edizione italiana di \u2018La startup digitale, guida pratica step by step\u2019 e ha scritto la prefazione all\u2019edizione italiana de \u2018La quarta era\u2019 di Byron Reese, ed \u00e8 co-autore di \u2018Cosa e Dove: strategie digitali di ricerca del lavoro\u2019, tutti editi da FrancoAngeli. In passato \u00e8 stato curatore di StartupDigest Italy, coordinatore scientifico del Forum per la Ricerca della Provincia Autonoma di Trento, board member di TechChill Milano advisor di di ScaleIT , ha collaborato con Il Sole 24 Ore \u00e8 stato direttore di Innov\u2019azione, bimestrale edito da Apsti, ha collaborato con Corriere Innovazione ed \u00e8 stato presidente del comitato di selezione del Premio Marzotto e advisor di Cetif-Universit\u00e0 Cattolica Milano.\",\"sameAs\":[\"https:\\\/\\\/www.abirascid.com\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/in\\\/emilabirascid\",\"https:\\\/\\\/x.com\\\/emilabirascid\"],\"url\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/author\\\/emil-abirascid\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Indaco, CDP VC and Fondazione ENEA invest in Valo Therapeutics","description":"Finnish start-up with offices also in Italy and Australia closes a EUR 19 million round to develop cancer treatments","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.startupbusiness.it\/en\/indaco-cdp-vc-and-fondazione-enea-invest-in-valo-therapeutics\/144873\/","og_locale":"en_US","og_type":"article","og_title":"Indaco, CDP VC and Fondazione ENEA invest in Valo Therapeutics","og_description":"Finnish start-up with offices also in Italy and Australia closes a EUR 19 million round to develop cancer treatments","og_url":"https:\/\/www.startupbusiness.it\/en\/indaco-cdp-vc-and-fondazione-enea-invest-in-valo-therapeutics\/144873\/","og_site_name":"Startupbusiness.it","article_published_time":"2025-03-10T11:15:38+00:00","article_modified_time":"2025-03-10T12:47:05+00:00","og_image":[{"width":480,"height":320,"url":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2025\/03\/AdobeStock_606895568-for-sarcoma.webp","type":"image\/webp"}],"author":"Emil Abirascid","twitter_card":"summary_large_image","twitter_creator":"@emilabirascid","twitter_misc":{"Written by":"Emil Abirascid","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.startupbusiness.it\/en\/indaco-cdp-vc-and-fondazione-enea-invest-in-valo-therapeutics\/144873\/#article","isPartOf":{"@id":"https:\/\/www.startupbusiness.it\/en\/indaco-cdp-vc-and-fondazione-enea-invest-in-valo-therapeutics\/144873\/"},"author":{"name":"Emil Abirascid","@id":"https:\/\/www.startupbusiness.it\/en\/#\/schema\/person\/4e2760db2cb7ca47d635ea3d8d8486dd"},"headline":"Indaco, CDP VC and Fondazione ENEA invest in Valo Therapeutics","datePublished":"2025-03-10T11:15:38+00:00","dateModified":"2025-03-10T12:47:05+00:00","mainEntityOfPage":{"@id":"https:\/\/www.startupbusiness.it\/en\/indaco-cdp-vc-and-fondazione-enea-invest-in-valo-therapeutics\/144873\/"},"wordCount":685,"commentCount":0,"image":{"@id":"https:\/\/www.startupbusiness.it\/en\/indaco-cdp-vc-and-fondazione-enea-invest-in-valo-therapeutics\/144873\/#primaryimage"},"thumbnailUrl":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2025\/03\/AdobeStock_606895568-for-sarcoma.webp","keywords":["australia","Europa","investments","italy","lifescience","startup"],"articleSection":["Funding News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.startupbusiness.it\/en\/indaco-cdp-vc-and-fondazione-enea-invest-in-valo-therapeutics\/144873\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.startupbusiness.it\/en\/indaco-cdp-vc-and-fondazione-enea-invest-in-valo-therapeutics\/144873\/","url":"https:\/\/www.startupbusiness.it\/en\/indaco-cdp-vc-and-fondazione-enea-invest-in-valo-therapeutics\/144873\/","name":"Indaco, CDP VC and Fondazione ENEA invest in Valo Therapeutics","isPartOf":{"@id":"https:\/\/www.startupbusiness.it\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.startupbusiness.it\/en\/indaco-cdp-vc-and-fondazione-enea-invest-in-valo-therapeutics\/144873\/#primaryimage"},"image":{"@id":"https:\/\/www.startupbusiness.it\/en\/indaco-cdp-vc-and-fondazione-enea-invest-in-valo-therapeutics\/144873\/#primaryimage"},"thumbnailUrl":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2025\/03\/AdobeStock_606895568-for-sarcoma.webp","datePublished":"2025-03-10T11:15:38+00:00","dateModified":"2025-03-10T12:47:05+00:00","author":{"@id":"https:\/\/www.startupbusiness.it\/en\/#\/schema\/person\/4e2760db2cb7ca47d635ea3d8d8486dd"},"description":"Finnish start-up with offices also in Italy and Australia closes a EUR 19 million round to develop cancer treatments","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.startupbusiness.it\/en\/indaco-cdp-vc-and-fondazione-enea-invest-in-valo-therapeutics\/144873\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.startupbusiness.it\/en\/indaco-cdp-vc-and-fondazione-enea-invest-in-valo-therapeutics\/144873\/#primaryimage","url":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2025\/03\/AdobeStock_606895568-for-sarcoma.webp","contentUrl":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2025\/03\/AdobeStock_606895568-for-sarcoma.webp","width":480,"height":320,"caption":"trattamenti oncologici"},{"@type":"WebSite","@id":"https:\/\/www.startupbusiness.it\/en\/#website","url":"https:\/\/www.startupbusiness.it\/en\/","name":"Startupbusiness.it","description":"May the Force be with you!","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.startupbusiness.it\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.startupbusiness.it\/en\/#\/schema\/person\/4e2760db2cb7ca47d635ea3d8d8486dd","name":"Emil Abirascid","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/84e46190ac811c9c62650621ceca8f65c1e967d6b06e6352fe183145dba0d7e9?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/84e46190ac811c9c62650621ceca8f65c1e967d6b06e6352fe183145dba0d7e9?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/84e46190ac811c9c62650621ceca8f65c1e967d6b06e6352fe183145dba0d7e9?s=96&d=mm&r=g","caption":"Emil Abirascid"},"description":"Emil Abirascid (\u30a8\u30df\u30fc\u30eb\u30fb\u30a2\u30d3\u30e9\u30b7\u30c3\u30c9), giornalista, fondatore e direttore di Startupbusiness, il primo magazine sull\u2019ecosistema startup e innovazione italiano. Co-fondatore di Designtech, l\u2019hub di innovazione che avvicina il mondo del design con quello della tecnologia. Advisor di Austrian Business Agency, Emil Banca, Fondazione Symbola, Fondazione Quadrans. Partecipa regolarmente a incontri, convegni, conferenze dedicate all\u2019ecosistema dell\u2019innovazione. E\u2019 stato co-organizzatore degli Italian Innovation Day and Series che si sono svolti dal dal 2016 al 2020 nelle citt\u00e0 di Tokyo in Giappone, Melbourne, Adelaide, Perth, Canberra in Australia e Singapore e co-organizzatore dell\u2019Italy India Innovation Day di AIICP 2021 e 2022. Ha curato il volume \u2018L\u2019innovazione che non ti aspetti. Contesti e visioni per l\u2019impresa\u2019 , l\u2019edizione italiana di \u2018La startup digitale, guida pratica step by step\u2019 e ha scritto la prefazione all\u2019edizione italiana de \u2018La quarta era\u2019 di Byron Reese, ed \u00e8 co-autore di \u2018Cosa e Dove: strategie digitali di ricerca del lavoro\u2019, tutti editi da FrancoAngeli. In passato \u00e8 stato curatore di StartupDigest Italy, coordinatore scientifico del Forum per la Ricerca della Provincia Autonoma di Trento, board member di TechChill Milano advisor di di ScaleIT , ha collaborato con Il Sole 24 Ore \u00e8 stato direttore di Innov\u2019azione, bimestrale edito da Apsti, ha collaborato con Corriere Innovazione ed \u00e8 stato presidente del comitato di selezione del Premio Marzotto e advisor di Cetif-Universit\u00e0 Cattolica Milano.","sameAs":["https:\/\/www.abirascid.com\/","https:\/\/www.linkedin.com\/in\/emilabirascid","https:\/\/x.com\/emilabirascid"],"url":"https:\/\/www.startupbusiness.it\/en\/author\/emil-abirascid\/"}]}},"author_name":"Emil Abirascid","categories_names":["Funding News"],"_links":{"self":[{"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/posts\/144873","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/users\/125"}],"replies":[{"embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/comments?post=144873"}],"version-history":[{"count":1,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/posts\/144873\/revisions"}],"predecessor-version":[{"id":144874,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/posts\/144873\/revisions\/144874"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/media\/144871"}],"wp:attachment":[{"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/media?parent=144873"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/categories?post=144873"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/tags?post=144873"},{"taxonomy":"companies","embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/companies?post=144873"},{"taxonomy":"journalist","embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/journalist?post=144873"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}